Battling Infection: Hospitals Seek High-Tech Solutions
The market for diagnostic and infection control products will see continued growth as hospitals and other providers look to the technology sector to help fight the battle against health care-associated infections and antibiotic-resistant organisms.
You may also be interested in...
The US market for infection control and biosafety products will see strong growth ahead as hospitals continue the battle against health care-associated infections with innovative products and services designed to prevent needlesticks, nosocomial infections, and the spread of antibiotic-resistant organisms.
Consano Medical is moving closer to FDA clearance for its Canary Catheter, a novel, continuous monitoring device that leverages an existing urinary catheter for the early detection of sepsis – a serious condition that costs hospitals more than $20 billion annually in the US alone.
Start-ups developing technologies to help hospitals avoid preventable medical errors known as “never events” are developing solutions to nosocomial infections, retained surgical objects, pressure ulcers, and medication errors.